MD-Logic Artificial Pancreas for Automatic Type 1 Diabetes Meals Management
NCT ID: NCT01901913
Last Updated: 2015-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2013-10-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will consist of a pilot study with two segments and a main study segment. The aim of each segment is detailed below:
1. Pilot Study - Segment 1 - Hybrid meal bolus ratio The aim of this segment is to evaluate the efficacy and safety of different pre-meal bolus dosing compared to full closed-loop operation with no meal announcement.
2. Pilot Study - Segment 2 - Insulin dosing during meal In this segment we would like to test the optimal distribution of insulin delivery during the meal.
3. Main study - Segment 3 - Automatic bolus calculator In this main segment of the study we will use the results and conclusions from the previous two pilot segments to develop the MD-Bolus Calculator for closed-loop control use. The safety and efficacy of this automated insulin bolus calculator will be tested in a randomized cross-over study that will compare postprandial glycemic control under MDLAP with and without the use of the MD-Bolus Calculator.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes
NCT01501032
Overnight MD-Logic
NCT01238406
Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home
NCT01726829
Personalized Automated Determination of Insulin Pump Setting for Subjects With Type 1 Diabetes Switching From MDI to Pump Therapy and Vice Versa- Safety and Efficacy Feasibility Study
NCT03574558
MD Logic Pump Advisor- Adults Study
NCT01157923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MD-bolus calculator for pre meal bolus
closed loop session with MD-bolus calculator for pre-meal bolus.
MD-bolus calculator for pre-meal bolus
No MD-bolus calculator for pre-meal bolus
closed loop session without MD-bolus calculator for pre-meal bolus
No MD-bolus calculator for pre-meal bolus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MD-bolus calculator for pre-meal bolus
No MD-bolus calculator for pre-meal bolus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 14-25 years
-\>1yr since diagnosis
* Insulin infusion pump therapy for at least 3 months
* HbA1c at inclusion ≤10%
* BMI \< 95th percentile for age and sex
* Patients willing to follow study instructions
Exclusion Criteria
* any episode of diabetic ketoacidosis within the month prior to study entry and/or severe hypoglycaemia resulting in seizure or loss of consciousness in the month prior to enrolment
* any concomitant disease that may influence metabolic control
* participation in any other interventional study
* known or suspected allergy to trial products
* any significant diseases (such as preexisting seizures or epilepsy) or conditions including psychiatric disorders, eating disorder and substance abuse that in the opinion of the investigator is likely to affect the subjects ability to complete the study or compromise patients safety
* Female subject who is pregnant or planning to become pregnant within the planned study duration.
14 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rabin Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schneider Children's Medical Center
Petah Tikva, Petah-Tikva, Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
rmc007418ctil
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.